Intrinsic Medicine Seeks U.S. IPO For IBS Treatments

Intrinsic Medicine has filed to raise investment via IPO. The firm is developing treatments for irritable bowel syndrome variants. Read more on INRX stock here.

Related Keywords

Boston ,Massachusetts ,United States ,Australia ,Washington ,Seattle ,Grand View ,Evelo Biosciences ,Alexander Martinez ,European Patent Office ,Company Technology ,Ironwood Pharmaceuticals ,View Research ,Arena Pharmaceuticals ,Corporate Development Of Ionis ,Sebella Pharmaceuticals ,Xiling Lab Pharmaceutical Co ,Development Laboratory ,Treatment Market Size Grand View Research ,Professionals Doing Research In Advanced Scientific Lab ,Boston Pharmaceuticals ,Salix Pharmaceuticals ,Finch Therapeutics Group ,Drug Development Pipeline ,Medical Development Laboratory ,Black Male Scientist Looking Under Microscope ,Analyzing Petri Dish ,Professionals Doing Research ,Advanced Scientific ,Side View Shot ,Washington Based Intrinsic ,Corporate Development ,Development Pipeline ,Grand View Research ,Compound Annual Growth Rate ,Market Size ,Bridge Note ,Spartan Capital Securities ,Capital Securities ,